Every public claim your brand makes is read three times: against an 81-standard rubric, by the AI engine behind our 93,000-ruling database, and by a licensed pharmacist who signs the result.
This page walks through the file, from order to delivery. $2,000 flat, five business days, nothing needed from you but URLs.
The review is external and read-only. You hand us URLs; we read every claim a regulator, platform, or acquirer would.
The audit is built to be safe to commission. It runs entirely on what the public can already see, and it is reported to you alone.
Nothing is sampled. Every phrase on every surface takes all three passes, and no finding ships until the third one signs it.
Every claim is ruled against all 81 banned-phrase standards drawn from FDA structure/function rules (21 CFR 101.93 · 21 U.S.C. §343(r)(6)), FTC Act §5 substantiation, Amazon seller policy, and Meta & Google ad rules.
The engine that has issued 93,000+ claim rulings across 1,149 top listings, and keeps scanning, reads your pages in hours, not weeks. It flags named conditions, drug claims, certification claims, and superlatives, and cross-references the FDA warning-letter database.
A licensed pharmacist reviews every finding, sets its severity, and signs the verdict and the rewrite. The machine does the sweep; a human seals it. That signature is what you hand a retailer, a payment processor, or an acquirer.
Three severity grades tell you what to fix first. Critical findings are the ones that draw warning letters and takedowns.
Pulled from a live scan of a sleep-category listing. Every finding in your report is formatted exactly like this.
“…has also been shown to soothe anxiety.”
“Promotes a sense of calm and supports restful sleep.”
Read what each half of that card does for the P&L. The strikethrough removes a takedown trigger from your best-selling page. The rewrite keeps the promise customers respond to, so the exposure goes away and the conversion stays.
A findings file built to be handed onward: to your copywriter to fix, to counsel to rely on, to a platform appeal or an acquirer’s data room as-is.
Scope confirmed in writing. We collect nothing but URLs; the review is entirely external and read-only. No scoping call required, and payment is on delivery.
The AI engine reads every claim across your listing, A+ content, product pages, ads, email flows, and search copy, and rules each one against all 81 standards.
The reviewing pharmacist reads every flagged claim, confirms or overturns the ruling, sets severity, and cites the statute or policy each finding breaches.
Every finding gets a paste-ready compliant rewrite that keeps the promise customers respond to. Language that sells and survives review.
The complete findings file, severity-rated, statute-cited, pharmacist signed. If we find nothing Critical, we say so in writing.
No. We are not a regulator and we report to you alone. Nothing we find is disclosed to Amazon, Meta, the FDA or the FTC. The exposure already exists in your live copy; the audit tells you where, before someone else finds it.
An ASIN or product URL, and access to whichever ad accounts and email flows you want in scope. The review is entirely external and read-only: no Seller Central access, nothing installed. Your time to start is about ten minutes, and payment is on delivery.
That is your commercial decision. Every finding carries a severity so you can triage: Critical findings are the ones that draw warning letters and suppressions. Some brands fix only those and accept the rest knowingly, which is a defensible position.
$2,000 flat. Five business days. Payment on delivery, and if we find nothing Critical, we say so in writing.